- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04294914
Catastrophizing and Virtual Reality's Impact on Pain in Patients With Fibromyalgia
Catastrophizing and Virtual Reality's Impact on the Pain Threshold During a Cold Pressor Test in Patients With Fibromyalgia: A Case-control Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Zealand
-
Naestved, Zealand, Denmark, 4700
- Interdisciplinary Paincenter Naestved, Naestved hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Able to understand, read and speak Danish
- Able to independently answer a questionnaire
- Able to give informed consent
Fibromyalgia group:
- Confirmed diagnosed with fibromyalgia
Controls:
- Healthy participants
Exclusion Criteria:
Applies for both groups:
- Signs of anxiety, depression and post-traumatic stress syndrome that require treatment
- Neurologic, musculoskeletal or mental illnesses that could influence the results.
- Parallel participating in other studies, that can influence this study
- Pregnancy
Fibromyalgia group:
- Regulation in medication
- Anticonvulsivant use the last week
- Serotonin-norepinephrine reuptake Inhibitor (SNRI) the last two weeks
- Tricykliske antidepressants (TCA) the last four weeks
Controls:
- No regular use of pain medication
- No current or previous history of subacute or ongoing pain
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Fibromyalgia
Individuals with fibromyalgia.
|
The participant submerges one limb into a tank of cold (1-2 ° C), circulating water.
The participant submerges one limb into a tank of cold (1-2 ° C), circulating water while interacting with a virtual reality environment
|
|
Experimental: Healthy controls
Healthy, pain-free individuals
|
The participant submerges one limb into a tank of cold (1-2 ° C), circulating water.
The participant submerges one limb into a tank of cold (1-2 ° C), circulating water while interacting with a virtual reality environment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain intensity
Time Frame: through study completion, an average of 90minutes
|
Pain intensity during the interventions is scored using a Visual Analog Scale or Numeric Rating Scale (0 = no pain and 10 = worst known pain)
|
through study completion, an average of 90minutes
|
|
Pain threshold
Time Frame: through study completion, an average of 90minutes
|
Pain threshold is defined as when the participants feel the sensation changing from an unpleasant feeling to a painful experience (measured in seconds)
|
through study completion, an average of 90minutes
|
|
Pain tolerance
Time Frame: through study completion, an average of 90minutes
|
Pain tolerance is when the participants no longer are able to withstand the pain (measured in seconds).
|
through study completion, an average of 90minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain catastrophizing
Time Frame: through study completion, an average of 90minutes
|
The pain catastrophizing score is measured by filling out the pain catastrophizing scale questionnaire. The pain catastrophizing scale consists of 13 sentences assessing pain-related thoughts or feelings. These are then divided into 3 domains: rumination, magnification and helplessness. The subject is asked to rate how well each sentence applies for them: 0 = not at all, 1 = to a slight degree, 2 = to a moderate degree, 3 = to a great degree and 4 = all the time. The total score on the questionnaire can lie between 0 - 52 where a higher score indicates higher levels of pain catastrophizing thoughts. |
through study completion, an average of 90minutes
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Steffan WM Christensen, PhD, Dept. Of Health Science and Technology, Aalborg University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SJ-822
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.